In conclusion, we demonstrated that MMPP is an anti-inflammatory compound that strongly inhibits the pro-inflammatory gene and mediator expression and production, respectively, by suppressing STAT3 activation and its downstream signalling pathway in human synoviocytes from patients with RA and murine macrophages. The gene discussed is STAT3; the disease is rheumatoid arthritis.